期刊文献+

TNFα增强肾小球系膜细胞Ⅰ型1,4,5-三磷酸肌醇受体表达受PKCα调控

The regulation roles of protein kinase C alpha in enhanced expression of type Ⅰ inositol 1,4,5-trisphophate receptors induced by tumor necrosis factor alpha
原文传递
导出
摘要 目的 通过研究蛋白激酶Cα(PKCα)参与调控肿瘤坏死因子α(TNFα)增强肾小球系膜细胞Ⅰ型1,4,5-三磷酸肌醇受体(IP3RI)表达的信号机制,揭示TNFα引起肝肾综合征肾小球滤过率(GFR)下降的分子机制.方法 选择大鼠系膜细胞株(GMCs)进行体外培养.按TNFα处理GMCs的不同时间点,分为对照组(D)、TNFα-2 h组、TNFα-4 h组、NFα-8 h组、TNFα-24 h组,另设2组分别为Sanfingol-8 h组(S)、TNFα+ Sanfingol共培养8h组(TS),共6组.应用免疫细胞化学染色、Western blot、Real time-PCR检测方法,观察TNFα孵育的GMCs中IP3RI表达的变化.结果 免疫细胞化学染色发现:IP3RI主要分布于GMCs的胞浆内,对照组阳性信号较弱,TNFα处理各组棕褐色阳性信号增强,以TNFα-8 h组最明显.Western blot分析发现:TNFα-4 h组、TNFα-8 h组、TNFα-24 h组与对照组差异有统计学意义(4 h:1.82±0.63,8 h:2.95±0.66,24 h:2.48±0.72,D:1±0.02,F=9.24,P<0.05).其中TNFα-8 h组、TNFα-24 h组IP3RI表达最高(P<0.05).S组、TS组与对照组差异无统计学意义(S:1.39 ±0.65,TS:1.35±0.37,P>0.05).Real time-PCR发现:TNFα处理各时间点组与对照组相比IP3 RI表达均明显增加,差异有统计学意义(2 h:3.35±1.97;4 h:3.16±1.35,8 h:3.70±1.76;24 h:4.49±1.70,D:1±0.01,F=6.167,P<0.05). TNFα各处理组组间差异无统计学意义(P>0.05).S组、TS组与对照组比较差异无统计学意义(S:1.53±0.79,TS:1.32±0.38,P>0.05).结论 IP3 RI主要分布于GMCs的胞浆内,TNFα可增加肾小球系膜细胞IP3 RI蛋白、mRNA的表达,并可被PKCα抑制剂Sanfingol所阻断,这可能是肝肾综合征时TNFα引起GFR下降的重要信号机制. Objective To investigate the signal mechanism of protein kinase C alpha(PKC-α)participated in enhanced expression of type Ⅰ inositol 1,4,5-trisphophate receptors (IP3 RI) induced by tumor necrosis factor alpha(TNFα),in order to delineate the mechanisms of decreased glomerular filtration rate (GFR) in hepatorenal syndrome caused by TNFα.Methods The glomerular mesangial cells (GMCs)line from rats was chosen as experimental material.GMCs were divided into control (D),TNFα-2 h,TNFα-4 h,TNFα-8 h,and TNFα-24 h groups.Moreover,another two groups were sanflngol-8h (S),TNFα + Sanfingol-8h(TS)groups.The effect of TNFα on the expression of IP3RI was detected by immunocytochemical staining,Western blotting,teal time-polymerase chain reaction (PCR) assays.Results Immunocytochemical staining demonstrated that IP3 RI was mainly distributed in cytoplasm of GMCs.Enhanced positive staining was determined in all TNFα-treated groups,especially in TNFα-8 h group.Western blotting demonstrated that the expression of IP3RI protein was significantly higher in TNFα-4 h,TNFα-8h and TNFα-24 h groups than control group(4 h:1.82 ± 0.63 ; 8 h:2.95 ± 0.66 ; 24 h:2.48 ± 0.72 ; D:1 ±0.02 ; F =9.24,P 〈 0.05).The expression of IP3 RI protein was the highest in TNFα-8 h and TNFα-24 h groups(P 〈0.05).No difference was found among S,TS,and control groups(S:1.39 ±0.65; TS:1.35± 0.37 ; P 〉 0.05).Real time-PCR found the expression of IP3 RImRNA was significantly higher in all TNFα-treated groups than control group(2 h:3.35 ± 1.97; 4 h:3.16 ± 1.35; 8 h:3.70 ± 1.76; 24 h:4.49±1.70; D:1 ±0.01; F =6.167,P 〈0.05).No difference was found among all TNFα-treated groups(P 〉0.05).No difference was found among S,TS,and control groups(S:1.53 ±0.79; TS:1.32 ± 0.38 ; P 〉 0.05).Conclusions IP3 RI was mainly distributed in cytoplasm of GMCs.TNFa could enhance the expression of IP3 RI protein and IP3 RI mRNA,which could be blocked by sanfingol,a PKCα inhibitor.It might be an important signal in the mechanisms of GFR decrease caused by TNFα in hepatorenal syndrome.
出处 《中国医师杂志》 CAS 2013年第8期1013-1017,共5页 Journal of Chinese Physician
基金 基金项目:国家自然科学基金(N030270607)
关键词 蛋白激酶CΑ 肝肾综合征 肾小球系膜细胞 肌醇磷酸类 代谢 肿瘤坏死因子α Protein kinase C-alpha Hepatorenal syndrome Mesangial cells Inositol phosphates/metabolism Tumor necrosis factor-alpha
  • 相关文献

参考文献16

二级参考文献59

  • 1吕飒,宋红丽,王静艳,刘沛.急性肝坏死小鼠血脑屏障通透性的改变[J].世界华人消化杂志,2004,12(6):1346-1348. 被引量:10
  • 2姚宇玫,胡申江,黄元伟,杨春虎,孙坚,朱朝晖,吴涛.肿瘤坏死因子α对心肌细胞内受磷蛋白表达和细胞内钙的调节作用[J].中国医学科学院学报,2005,27(6):767-771. 被引量:4
  • 3闻颖,崔巍,刘沛.暴发性肝衰竭时肾脏Ⅰ型1,4,5-三磷酸肌醇受体表达增加[J].中华肝脏病杂志,2007,15(6):403-407. 被引量:5
  • 4Arroyo V, Gin s P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology, 1996,23( 1 ) : 164-176.
  • 5Duvoux C, Zanditenas D, H 6 zode C, et al. Effects of noradrenalin and albumin in patients with type | hepatorenal syndrome:a pilot study. Hepatology, 2002,36(2 ) : 374-378.
  • 6Ruiz-del-Arbol L,Monescillo A,Amcena C,et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology, 2005,42( 2 ) : 439-447.
  • 7Ruiz-del-Arbol L,Urman J,Fernandez J,et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 2008,38 ( 5 ) : 1210- 1218.
  • 8Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective muhicenter study. Gastroenterology, 2002,122 (4) : 923-930.
  • 9Bardi A, Sapunar J, Oksenberg D, et al. Intrarenal arterial doppler uhrasonography in cirrhotic patients with aseites, with and without hepatorenal syndrome. Rev Med C hil, 2002,130(2): 173-180.
  • 10Muto Y, Nouri-Aria KT, Meager A, et al. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet , 1988, 2:72-74.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部